SAB Biotherapeutics SABS Growth Metrics (2021-2026)

NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

SAB Biotherapeutics Quarterly Growth Metrics

Periods 23 quarters
Latest Sep 2026

SAB Biotherapeutics reported revenue growth of 8.26% and asset growth of 102.60% for the quarter ended Sep 2026. These growth metrics cover 23 quarters of results from Mar 2021 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Total Debt (QoQ)
-42.13%-73.22%-91.02%5,154.50%-66.18%-74.83%384.07%94.01%-20.50%-26.29%-49.77%
Total Debt Growth (3y)
-9.58%-46.45%-48.92%
Total Debt Growth (1y)
26.39%-26.85%-57.25%-59.81%2,065.45%-20.05%87.97%450.36%-73.75%-83.42%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-26.02%37.78%-36.51%1.46%8.71%-4.10%6.97%-0.86%212.04%-69.05%-2.59%74.38%-35.72%-9.08%2.29%27.75%295.71%72.26%32.73%2.62%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
73.32%75.65%53.22%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
20.93%11.54%6.00%1.15%-11.94%3.24%11.48%71.48%108.45%124.00%126.59%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
157.11%31.48%-34.34%-3.52%-32.85%13.15%10.56%217.36%2.43%-6.73%64.07%-66.20%-0.73%4.25%-23.63%370.18%790.76%1,055.82%828.46%
Revenue (QoQ)
-24.67%6.74%-46.20%-43.47%-39.80%-73.11%-85.28%1,381.98%-75.93%209.69%-72.14%
Revenue Growth (5y)
-35.74%
Revenue Growth (3y)
-61.79%-75.64%-78.19%-44.55%8.26%
Revenue Growth (1y)
-30.27%-65.13%-75.55%-80.46%-95.08%-98.65%-64.69%-85.88%62.55%207.70%-62.40%162.75%
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.00M959.000.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M0.05M-0.53M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.16M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.12M-0.39M-0.34M-0.87M-0.19M-0.12M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.30M-0.25M0.14M0.05M
Return on Equity [ROE] (QoQ)ROE (QoQ)
239.00-733.000.00M550.000.00M0.00M0.00M0.00M0.00M-905.000.00M64.000.00M-0.01M0.02M0.00M-886.00-592.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.01M-0.01M-0.02M0.01M0.01M0.01M0.01M0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M-0.01M-0.01M-0.01M-0.01M0.00M0.01M0.00M723.00-0.01M-0.01M0.01M0.01M0.01M0.02M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M0.00M-567.000.00M0.00M0.00M0.00M0.00M0.00M0.00M99.000.00M0.00M0.01M0.00M26.00-203.00-728.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M-0.01M-0.01M0.00M0.00M0.01M0.01M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.01M-0.01M-0.01M0.00M-524.000.00M0.00M0.00M0.00M-0.01M-0.01M0.01M0.01M0.01M0.01M671.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-593.00-784.00-972.00387.000.00M0.00M0.00M0.00M0.00M-914.000.00M875.000.00M0.00M0.01M-993.00-787.00-538.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.01M-0.01M0.01M0.00M0.01M0.01M0.01M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M0.00M641.000.00M657.00517.000.00M0.00M0.01M0.01M0.01M0.01M-0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
2.71%-0.55%-3.24%-3.25%-3.77%-3.78%-4.21%-4.29%-9.29%-5.48%-4.99%-4.41%-4.93%-5.15%-5.37%1.46%3.81%3.01%10.00%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-2.17%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
9.96%-14.18%-16.36%-17.67%-18.28%-16.98%-14.85%-12.89%-8.78%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
63.78%-4.37%-10.41%-13.32%-14.19%-15.11%-19.98%-21.40%-22.04%-22.13%-18.39%-18.10%-18.43%-13.42%-5.46%2.68%19.35%
Operating Margin (QoQ)
0.00M959.000.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M
Operating Margin Growth (5y)
-0.16M
Operating Margin Growth (3y)
-0.12M-0.39M-0.87M-0.19M-0.12M
Operating Margin Growth (1y)
-0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.25M0.05M
Operating Income (QoQ)Op. Inc (QoQ)
-84.05%8.67%2.45%-19.32%-0.67%5.83%12.50%17.81%-254.58%39.65%10.44%-10.86%11.50%-7.63%9.66%-30.28%-24.38%-26.81%-16.90%-10.79%
Operating Income Growth (5y)Op. Inc Growth (5y)
-92.70%-52.09%-45.36%
Operating Income Growth (3y)Op. Inc Growth (3y)
-151.96%-52.57%-41.52%-10.87%-17.11%-14.15%-17.54%-26.13%-39.28%-53.40%-69.45%
Operating Income Growth (1y)Op. Inc Growth (1y)
-924.07%-127.78%-95.65%-7.02%-10.36%1.01%31.82%-140.12%-53.89%-57.52%-112.47%46.97%5.43%4.60%-12.11%-57.56%-85.64%-140.21%-104.27%
Net Margin (QoQ)
-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M
Net Margin Growth (5y)
-0.14M
Net Margin Growth (3y)
-0.05M-0.28M-0.98M0.76M-0.10M
Net Margin Growth (1y)
2.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M-0.24M-0.88M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-184.44%108.53%-584.45%-48.16%-11.28%6.61%6.43%25.85%-347.97%78.01%-45.96%-41.09%-10.10%54.39%-94.62%549.33%-137.10%-11.91%-19.20%0.85%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-351.40%-72.75%-50.20%-40.58%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-1,264.55%-77.21%-35.61%-36.59%0.45%-93.73%-28.42%103.46%-28.89%-36.90%-48.41%-63.50%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-128,307.03%-30.07%-62.36%-74.24%31.83%-845.93%-44.07%27.89%-190.26%31.66%-6.61%-102.84%50.15%-3.40%-37.88%539.11%-47.97%-263.09%-122.37%-149.07%
Net Income (QoQ)
-184.44%108.53%-584.45%-48.16%-11.28%6.61%6.43%25.85%-347.97%78.01%-45.96%-41.09%-10.10%54.39%-94.61%549.33%-137.10%-11.91%-19.20%0.85%
Net Income Growth (5y)
-351.40%-72.75%-50.20%-40.58%
Net Income Growth (3y)
-1,264.55%-77.21%-35.61%-36.59%0.45%-93.74%-28.42%103.46%-28.89%-36.90%-48.41%-63.50%
Net Income Growth (1y)
-128,307.03%-30.07%-62.36%-74.24%31.83%-845.93%-44.07%27.89%-190.26%31.66%-6.61%-102.84%50.15%-3.41%-37.88%539.11%-47.97%-263.07%-122.37%-149.07%
Net Cash Flow (QoQ)NCF (QoQ)
5,457.81%-159.51%66.20%-43.03%181.05%-129.59%-166.04%-1.20%1,111.83%-178.53%107.48%-355.31%100.19%-21,337.52%35.49%1,310.58%-171.88%153.99%-223.57%148.92%
Net Cash Flow Growth (5y)NCF Growth (5y)
-194.19%5.88%-4.55%63.47%
Net Cash Flow Growth (3y)NCF Growth (3y)
760.86%-97.07%32.41%-160.47%-91.86%42.25%28.37%72.25%-68.20%91.61%-32.73%46.29%
Net Cash Flow Growth (1y)NCF Growth (1y)
33,841.08%-327.95%41.47%-1,699.02%-76.68%88.41%8.74%35.43%706.03%-2,039.29%160.16%-51.78%-99.97%92.24%-166.95%417.44%-119,314.81%403.09%-480.60%-76.54%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-118.16%15.96%1.38%-20.36%18.92%10.60%-7.32%11.19%-217.34%38.46%26.55%-32.28%2.56%-9.65%1.80%-92.60%15.15%-28.25%-18.30%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-99.30%-57.75%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-150.82%-41.59%-41.83%-8.42%-18.47%-18.30%-38.37%-40.49%-58.45%-63.68%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-960.35%-138.00%-117.63%19.12%13.97%6.38%30.92%-170.40%-86.15%-27.41%-89.77%41.73%-3.82%-38.80%-102.09%-75.97%-105.82%-147.96%
Income After Tax (QoQ)
-184.44%108.53%-584.45%-48.16%-10.92%6.31%6.43%25.85%-347.97%78.01%-45.96%-41.09%3.92%-8.41%9.25%-23.36%-25.41%-25.64%-14.29%-19.19%
Income After Tax Growth (5y)
-72.98%-49.17%-44.85%
Income After Tax Growth (3y)
-77.21%-35.61%-36.59%4.87%-134.73%-27.00%-19.47%-24.46%-37.25%-46.71%-71.86%
Income After Tax Growth (1y)
-30.07%-62.36%-74.24%32.05%-845.93%-44.07%27.89%-191.21%31.66%-6.61%-102.84%56.50%-114.48%-33.35%-16.60%-52.19%-76.39%-122.14%-114.63%
Free Cash Flow (QoQ)FCF (QoQ)
-1,371.72%-50.48%53.55%-58.02%79.08%2.74%-202.51%-6.73%-157.27%19.50%28.58%17.73%-49.99%18.67%8.26%-82.43%-28.56%9.07%25.09%-25.72%
Free Cash Flow Growth (5y)FCF Growth (5y)
-341.23%-32.06%-3.02%-93.65%
Free Cash Flow Growth (3y)FCF Growth (3y)
-1,004.43%-50.93%7.60%-136.50%-9.81%10.55%-12.22%-17.73%-115.65%-110.86%-32.41%-39.84%
Free Cash Flow Growth (1y)FCF Growth (1y)
-72,069.97%-244.05%48.62%-1,504.71%76.90%85.07%2.75%34.31%-707.91%-568.65%-57.87%-21.69%29.06%28.33%7.95%-104.14%-74.98%-95.64%-59.75%-10.09%
FCF Margin (QoQ)
-0.01M0.00M0.00M-0.01M0.01M-0.02M-0.55M0.53M-0.40M0.33M-0.18M
FCF Margin Growth (5y)
-0.09M
FCF Margin Growth (3y)
-0.12M-0.29M-0.83M-0.19M-0.05M
FCF Margin Growth (1y)
-0.01M0.00M-0.02M0.00M-0.02M-0.57M-0.02M-0.44M-0.09M0.28M-0.39M0.12M
EPS (Diluted) (QoQ)
-170.23%105.09%-616.19%-48.05%-10.02%19.35%6.48%28.66%-325.18%86.86%-45.75%-41.02%-10.07%54.54%-94.56%153.64%-147.09%-28.17%19.95%-4.47%
EPS (Diluted) Growth (5y)
-141.73%-21.99%24.28%28.38%
EPS (Diluted) Growth (3y)
-975.19%-45.54%11.22%10.59%33.72%-66.30%0.68%33.04%46.64%37.73%40.88%32.86%
EPS (Diluted) Growth (1y)
-126,767.88%-57.15%1.93%-5.17%57.18%-778.13%-22.87%40.79%-128.81%62.73%41.92%-14.80%70.28%-2.85%-37.29%152.22%77.66%37.01%74.08%-150.48%
EPS (Basic) (QoQ)
-53.90%105.41%-585.73%-48.05%-10.02%19.35%6.48%28.66%-325.18%86.86%-45.75%-41.02%-10.07%54.54%-94.56%491.75%-120.48%59.65%19.95%15.19%
EPS (Basic) Growth (5y)
-200.84%-15.87%46.81%38.62%
EPS (Basic) Growth (3y)
-953.25%-28.79%50.72%25.88%33.72%-64.43%0.68%66.22%21.56%37.73%40.88%37.37%
EPS (Basic) Growth (1y)
-119,157.16%-94.27%83.22%40.10%57.18%-738.12%-22.87%40.79%-128.81%62.73%41.92%-14.80%70.28%-2.85%-37.29%481.39%29.04%37.01%74.08%-105.61%
EBT (QoQ)
-184.44%109.33%-551.54%-45.35%-10.92%6.31%6.43%25.85%-347.97%78.01%-45.96%-41.09%3.92%-8.41%9.25%-23.36%-25.41%-25.64%-14.29%-19.19%
EBT Margin (QoQ)
-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M
EBT Margin Growth (5y)
-0.16M
EBT Margin Growth (3y)
-0.05M-0.28M-0.86M-0.18M-0.12M
EBT Margin Growth (1y)
81.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M-0.12M0.04M
EBT Growth (5y)
-72.98%-49.17%-44.85%
EBT Growth (3y)
-77.21%-35.61%-36.59%4.87%-128.93%-26.19%-19.47%-24.46%-37.25%-46.71%-71.86%
EBT Growth (1y)
-23.53%-65.49%-74.24%32.05%-782.08%-41.34%27.89%-191.21%31.66%-6.61%-102.84%56.50%-114.48%-33.35%-16.60%-52.19%-76.39%-122.14%-114.63%
EBIT (QoQ)
-84.05%8.67%2.45%-19.32%-0.67%5.83%12.50%17.81%-254.58%39.65%10.44%-10.86%11.50%-7.63%9.66%-30.28%-24.38%-26.81%-16.90%-10.79%
EBIT Margin (QoQ)
0.00M959.000.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M
EBIT Margin Growth (5y)
-0.16M
EBIT Margin Growth (3y)
-0.12M-0.39M-0.87M-0.19M-0.12M
EBIT Margin Growth (1y)
-0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.25M0.05M
EBIT Growth (5y)
-92.70%-52.09%-45.36%
EBIT Growth (3y)
-151.96%-52.57%-41.52%-10.87%-17.11%-14.15%-17.54%-26.13%-39.28%-53.40%-69.45%
EBIT Growth (1y)
-924.07%-127.78%-95.65%-7.02%-10.36%1.01%31.82%-140.12%-53.89%-57.52%-112.47%46.97%5.43%4.60%-12.11%-57.56%-85.64%-140.21%-104.27%
EBITDA Margin (QoQ)
0.00M935.000.00M-0.01M-0.01M-0.08M-0.54M0.62M-0.55M0.49M-0.25M
EBITDA Margin Growth (5y)
-0.15M
EBITDA Margin Growth (3y)
-0.10M-0.35M-0.80M-0.18M-0.12M
EBITDA Margin Growth (1y)
-0.01M-0.01M-0.02M-0.03M-0.11M-0.64M-0.01M-0.55M0.01M0.30M-0.22M0.04M
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-228.46%-95.52%53.36%-78.03%80.36%-3.26%-205.11%-5.48%-160.20%20.05%28.21%18.47%-51.50%18.20%8.26%-82.43%-28.56%14.93%31.04%-32.34%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-341.23%-28.54%-9.03%-40.27%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-1,002.58%-46.39%-6.52%-54.07%-25.02%6.50%-17.16%-18.12%-120.96%-107.14%-26.17%-36.08%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-48,526.09%-200.89%30.35%-308.53%68.12%83.16%-10.14%34.74%-764.73%-569.48%-57.53%-21.75%29.11%27.47%7.32%-107.39%-75.99%-83.03%-37.58%0.20%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
26.83%45.77%52.16%87.19%-50.00%81.91%-6.50%-80.11%-66.11%-46,108.90%135.78%-110.27%909.51%-49.94%11.28%-2,598.47%98.69%-3,745.50%92.56%224.28%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-103.30%-7.11%31.15%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-155.05%73.68%29.06%81.21%78.07%118.85%-1,082.69%-143.84%-1,355.28%-499.33%431.97%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
32.23%82.31%97.57%95.01%98.34%96.30%47.96%42.37%-147,126.32%49,556.96%-2,721.23%13,849.21%114.90%-53.67%-11,166.98%-118.30%-1,505.40%-193.95%104.67%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
208.88%-32.52%-25.85%-49.86%80.59%-13.20%-40.47%-68.80%2,232.16%-75.19%22.86%-46.64%-3.28%-36.61%-34.54%696.94%-64.31%95.37%-59.71%74.65%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-3.59%0.39%-4.18%6.08%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
64.92%-11.33%19.00%-5.06%-35.53%-36.86%-39.43%52.28%-11.29%16.25%2.07%81.23%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
163.33%11.33%62.39%-22.50%-54.69%-41.72%-53.21%-70.89%275.93%7.46%121.78%279.31%-84.27%-59.81%-78.59%219.83%18.04%263.80%123.90%-50.93%
Capital Expenditures (QoQ)Capex (QoQ)
-26.83%-42.53%-54.85%-87.19%50.00%-81.91%6.50%276.06%-20.45%90.20%-59.32%91.01%-44.79%61.27%-15.31%
Capital Expenditures Growth (5y)Capex Growth (5y)
-12.25%-14.46%-16.09%
Capital Expenditures Growth (3y)Capex Growth (3y)
-59.13%-75.25%-68.56%-71.38%258.73%311.94%150.63%
Capital Expenditures Growth (1y)Capex Growth (1y)
-28.19%-82.31%-97.57%-95.01%-98.43%-96.30%8.66%-42.37%505.98%131.49%17.58%-18.40%
Assets (QoQ)
-30.61%-15.59%-13.26%-11.62%-3.05%-16.17%-16.94%-20.05%196.23%-14.97%-13.28%-13.08%-17.85%-13.75%-20.96%508.87%-5.80%43.78%-4.13%-1.08%
Assets Growth (5y)
25.04%16.20%15.26%15.04%
Assets Growth (3y)
14.08%-15.26%-19.15%-22.80%-18.33%-17.74%-20.25%51.74%50.29%79.91%88.72%102.60%
Assets Growth (1y)
43.52%-41.60%-49.26%-55.09%-37.26%-37.69%-40.34%-46.03%64.90%67.26%74.63%89.85%-47.35%-46.59%-51.32%241.00%291.01%551.81%690.62%28.45%

SAB Biotherapeutics Growth Metrics API

Pull SAB Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SABS&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY